Global Markets for Medical Imaging Reagents and Analysis Equipment

Jan 2013| HLC040D| BCC Publishing

Report Highlights

The global medical imaging market was valued at $25.4 billion in 2011 and should reach $26.7 billion in 2012. Total market value is expected to reach nearly $34.1 billion in 2017 after increasing at a five-year compound annual growth rate (CAGR) of 5%.

SCOPE OF THE STUDY

The scope of this study encompasses imaging technology in the field of medicine. BCC analyzes each imaging market and its applications, regulatory environment, technology, market projections and market shares. Technological issues include the latest trends and developments. The emerging market for enzyme inhibitors includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand, among others.

Frequently Asked Questions (FAQs)

Analyst Credentials

Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Global Markets for Medical Imaging Reagents and Analysis Equipment195Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY2Free
Chapter- 3: OVERVIEW26Free
Chapter- 4: REGULATORY ISSUES26Free
Chapter- 5: NEW DEVELOPMENTS/ TECHNOLOGICAL INNOVATIONS5Free
Chapter- 6: GLOBAL MARKET ANALYSIS FOR IMAGING TECHNOLOGIES 27Free
Chapter- 7: MARKET ANALYSIS FOR X-RAYS AND COMPUTED TOMOGRAPHY29Free
Chapter- 8: MARKET ANALYSIS FOR MAGNETIC RESONANCE IMAGING16Free
Chapter- 9: MARKET FOR ULTRASOUND IMAGING16Free
Chapter- 10: MARKET FOR POSITRON EMISSION TOMOGRAPHY16Free
Chapter- 11: PATENT ANALYSIS 9Free
Chapter- 12: DEMAND AND USE4Free
Chapter- 13: C. CRAMER & CO. GMBH15Free
Chapter- 14: APPENDIX I-ABBREVIATIONS1Free
Published - Jan-2010| Analyst - Shalini Shahani Dewan| Code - HLC040C

Report Highlights

  • Global revenue of the imaging market was worth approximately $21.8 billion in 2008, a figure that further increased to $22.6 billion in 2009. This is projected to reach $29 billion in 2014, at a CAGR of 5.1% between 2009 and 2014.
  • The largest segment X-ray and computed tomography was nearly $9.2 billion in 2008; this further increased to $9.3 billion in 2009, this is projected to reach $11.3 billion in 2014, for a 5-year CAGR of 3.9%.
  • The Second largest segment ultrasound was nearly $5 billion in 2008; this further increased to $5.1 billion in 2009, this is projected to reach $6.1 billion in 2014, for a 5-year CAGR of 3.4%.

Published - Dec-2006| Analyst - Amy Brock| Code - HLC040B

Report Highlights

  • The U.S. market for medical imaging reagents and analysis tools is valued at a little more than $4.9 billion in 2006 and is expected to grow at an average annual growth rate of 11.9% to reach over $8.4 billion in 2011.
  • Imaging reagents currently comprise the largest segment with a value of $2.97 billion in 2006. Medical imaging reagents are expected to increase at an average annual rate of 10.5% to reach $4.9 billion in 2011. The market for imaging reagents is currently led by radiopharmaceuticals for nuclear medicine imaging. The market for these reagents was over $1 billion in 2006 and is expected to grow with an average annual rate of 11.8% to surpass $1.7 billion in 2011. Ultrasound imaging reagents are expected to experience the most significant growth with an average annual rate of 36% to reach $252.8 million in 2011.
  • Within the image analysis market, tools for the analysis of ultrasound images were $190.5 million in 2006 and are expected to grow at an average annual rate of 13.6% to reach $360.6 in 2011.
Published - May-2004| Analyst - Shalini Shahani Dewan| Code - HLC040A

Report Highlights

  • The total U.S. market for imaging reagents was $2.8 billion in 2003 and is expected to grow to $ 3.9 billion by 2008 at an AAGR (average annual growth rate) of 6.9%.
  • While currently the largest market, the x-ray segment appears stagnant, increasing at a very low rate, while the ultrasound market is rising rapidly with many new developments.
  • The MRI reagent market is the prime market for today since a good number of products are available and many more are in the pipeline.
  • Sales of reagents for cardiovascular applications were $770 million in 2003 and are expected to rise at an AAGR of 7.0%.
  • Reagents used in oncology and GIT are rising at AAGRs of 7.0% and 5.1%, respectively.

Global Markets for Medical Imaging Reagents and Analysis Equipment

Single User License: $2750

Become a Member

Already a member? Login to access this report free.

Have a Question? Ask Us.

Why BCC Research.?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
RELATED REPORTS